Aquestive Therapeutics, Inc. (35) | Uncategorized (4)

Recent Contracts

Consent Fee Letter, dated October 7, 2021, among Aquestive Therapeutics, Inc. and the Noteholder parties thereto (Filed With SEC on October 8, 2021)
Letter Agreement between the Company and A. Ernest Toth, Jr. , effective on June 15, 2021 (Filed With SEC on August 3, 2021)
Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 11, 2020)
Collateral Agreement dated as of July 15, 2019 among Aquestive Therapeutics, Inc., as Issuer, the Other Grantors from time to time party thereto, U.S. Bank National Association,... (Filed With SEC on July 16, 2019)